Abstract:Abstract Programmed Cell Death 4 (Pdcd4) is a novel tumor suppressor that frequently exhibits down-regulated expression in several types of cancer. In colon cancer tissues, expression level of Pdcd4 is continuously down-regulated in the order of normal-adenoma-carcinoma. Over-expression of Pdcd4 has been demonstrated to inhibit 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced transformation and tumor phenotype. In addition to cultured cells, Pdcd4 transgenic mice that over-express Pdcd4 in the epidermis show significant reductions in 7,12-dimethylbenz(a)anthracene (DMBA)/TPA induced skin papilloma formation and carcinoma incidence. Knock-out of Pdcd4 expression in mice results in induction of lymphomas with frequent metastases to the liver and kidney, and an increase in DMBA/TPA induced skin papilloma formation and carcinoma incidence. These findings suggest that Pdcd4 suppresses carcinogenesis not only at an early stage (tumor promotion), but also at a late stage (tumor progression) in both cultured cells and transgenic mice. Recently, we showed that aerosol delivery of pdcd4 cDNA into a murine lung inhibits cell proliferation and enhances apoptosis in K-ras null mice and AP-1 reporter mice. Moreover, immunohistochemical studies showed that expression of Pdcd4 is inversely correlated with the proliferation marker, Ki-76, in the human tissues of intraductal papillary mucinous carcinoma. However, the mechanisms involved in these processes remain unknown. In this study, we found that knockdown of Pdcd4 promoted cell proliferation and up-regulated cyclin D1 expression. Previously, we demonstrated that Pdcd4 knockdown activated NF-κB dependent transcription. Mutations of NF-κB binding sites on the cyclin D1 promoter attenuated the cyclin D1 promoter activity induced by Pdcd4 knockdown. In addition, knockdown of NF-κB/IαB kinase (IKK) ≤ or IKKα, the kinase regulating NF-κB activation, inhibited cyclin D1 promoter activity and cyclin D1 expression, indicating that up-regulation of cyclin D1 by Pdcd4 knockdown is contributed, at least in part, by NF-κB activation. To investigate the mechanism of how Pdcd4 knockdown activates NF-κB, we found that the level of AKT phosphorylation and AKT kinase activity were increased in the Pdcd4 knockdown cells. Conversely, ectopic expression of Pdcd4 inhibited AKT phosphorylation and cyclin D1 expression, suggesting that Pdcd4 regulates AKT activity and cyclin D1 expression. Furthermore, knockdown of AKT in the Pdcd4 knockdown cells inhibited IKK phosphorylation, NF-κB activation, cyclin D1 promoter activity, and cyclin D1 expression as well as cell proliferation. Taken together, these findings suggest that activation of NF-κB by Pdcd4 knockdown through AKT contributes to the elevated cyclin D1 expression, thus provide new insights into how loss of Pdcd4 expression promotes tumor development. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 2244. doi:1538-7445.AM2012-2244

P12(Cdk2-Ap1) Inhibits Breast Cancer Cell Proliferation and in Vivo Tumor Growth

[Effect of CDK2-AP1 Gene Over-Expression on Proliferation and Cell Cycle Regulation of Breast Cancer Cell Line MCF-7].

P12(Cdk2-Ap1) Interacts with Cd82 to Regulate the Proliferation and Survival of Human Oral Squamous Cell Carcinoma Cells

KCTD12 Promotes G1/S Transition of Breast Cancer Cell Through Activating the AKT/FOXO1 Signaling

Development of CDK12 as a Cancer Therapeutic Target and Related Inhibitors

Critical Role of CDK11p58 in Human Breast Cancer Growth and Angiogenesis

CDK12 loss inhibits cell proliferation by regulating TBK1 in non-small cell lung cancer cells

p27 inhibits CDK6/CCND1 complex formation resulting in cell cycle arrest and inhibition of cell proliferation

Cyclin-dependent kinase 2-associated protein 1 suppresses growth and tumorigenesis of lung cancer.

Dec1 Regulates Breast Cancer Cell Proliferation by Stabilizing Cyclin E Protein and Delays the Progression of Cell Cycle S Phase

C-terminal Binding Protein-2 Promotes Cell Proliferation and Migration in Breast Cancer Via Suppression of P16ink4a

Increased Expression of Cyclin D1 in a Murine Mammary Epithelial Cell Line Induces P27kip1, Inhibits Growth, and Enhances Apoptosis.

KLF12 Promotes the Proliferation of Breast Cancer Cells by Reducing the Transcription of P21 in a P53-Dependent and P53-Independent Manner

CDK11 P58 Inhibits ERα-positive Breast Cancer Invasion by Targeting Integrin Β3 Via the Repression of ERα Signaling

P21(Cip1) Attenuates Ras- and C-Myc-Dependent Breast Tumor Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Gene Expression in Vivo

AP-1 Blockade Prevents Breast Cancer Development by Suppressing Cyclin D and E2F Factors.

Knocking Down Cyclin D1b Inhibits Breast Cancer Cell Growth and Suppresses Tumor Development in a Breast Cancer Model

INHIBITION EFFECT OF Cyclind1 ON CELL PROLIFERATION AND TRANSCRIPTION OF Cycline, CDK2 AND P21cip1 IN HUMAN BREAST CANCER CELL LINE

CDK12 inhibition enhances sensitivity of HER2+ breast cancers to HER2-TKI via suppressing PI3K/AKT

CDK12: A Potent Target and Biomarker for Human Cancer Therapy

Abstract 2244: AKT Activation by Pdcd4 Knockdown Upregulates Cyclin D1 Expression and Promotes Cell Proliferation